Elpiscience Biopharmaceuticals

OverviewSuggest Edit

Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy. It has a pipeline of innovative molecules in discovery, covering a range of targets with a particular focus on innate immunity and tumor microenvironment.

TypePrivate
Founded2017
Websiteelpiscience.com

Latest Updates

Employees (est.) (May 2020)14(+56%)

Elpiscience Biopharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2017

Elpiscience Biopharmaceuticals total Funding

$155 m

Elpiscience Biopharmaceuticals latest funding size

$100 m

Time since last funding

5 months ago

Elpiscience Biopharmaceuticals investors

Elpiscience Biopharmaceuticals's latest funding round in December 2019 was reported to be $100 m. In total, Elpiscience Biopharmaceuticals has raised $155 m
Show all financial metrics

Elpiscience Biopharmaceuticals Online and Social Media Presence

Embed Graph

Elpiscience Biopharmaceuticals Frequently Asked Questions

  • When was Elpiscience Biopharmaceuticals founded?

    Elpiscience Biopharmaceuticals was founded in 2017.

  • How many employees does Elpiscience Biopharmaceuticals have?

    Elpiscience Biopharmaceuticals has 14 employees.

  • Who are Elpiscience Biopharmaceuticals competitors?

    Competitors of Elpiscience Biopharmaceuticals include Acousia Therapeutics, Protein Dynamic Solutions and Advansta.